Literature DB >> 21854662

[Lipoblastoma and lipoblastomatosis: especially in children].

Martine T P Besouw1, Piet F L Verlinde, Anne M Uyttebroeck, Marleen M Renard.   

Abstract

Lipoblastoma and lipoblastomatosis are rare benign fatty tumours that mainly occur in children under the age of 3 years. Several body sites can be affected. The term 'lipoblastoma' is reserved for an encapsulated neoplasm; 'lipoblastomatosis' for tumours demonstrating infiltrative growth. Most of the clinical symptoms arise from a mass effect of the tumour on surrounding tissues. The tumours should be differentiated from lipoma, myxoid liposarcoma and hibernoma. A clear distinction can be made by cytogenetic analysis, since each of these tumours is known for its own typical genetic abnormalities. In lipoblastoma and lipoblastomatosis, these include a breakpoint in the 8q11-13 region or polysomy of chromosome 8, both leading to the activation of the oncogenic pleomorphic adenoma gene 1 (PLAG1) on 8q12. Treatment consists of surgical resection; there is no need for radiotherapy or chemotherapy. Clinical outcome depends on the completeness of the resection and damage that is done to the surrounding tissues during surgery.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21854662

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  3 in total

1.  Spinal dumbbell lipoblastoma: a case-based update.

Authors:  Spazzapan Peter; Srpčič Matevž; Prestor Borut
Journal:  Childs Nerv Syst       Date:  2016-07-21       Impact factor: 1.475

Review 2.  Lipoblastoma: a clinicopathologic review of 23 cases from a major tertiary care center plus detailed review of literature.

Authors:  Jamshid Abdul-Ghafar; Zubair Ahmad; Muhammad Usman Tariq; Naila Kayani; Nasir Uddin
Journal:  BMC Res Notes       Date:  2018-01-17

Review 3.  Lipoblastoma of scalp in a 4-month-old patient: an extremely rare case report and review of the literature.

Authors:  Fatih Demir; Sait Öztürk; Hilal Balta; Fatih Serhat Erol
Journal:  Childs Nerv Syst       Date:  2021-08-09       Impact factor: 1.532

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.